Frontiers of MicroRNA Signature in Non-small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related deaths worldwide and non-small cell lung cancer (NSCLC) accounts for more than 80% of all lung cancer cases. Recent advancements in diagnostic tools, surgical treatments, chemotherapies, and molecular targeted therapies that improved the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xinping, Kudo, Masahisa, Huang, Xiangjie, Sui, Hehuan, Tian, Haishan, Croce, Carlo M., Cui, Ri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058364/
https://www.ncbi.nlm.nih.gov/pubmed/33898432
http://dx.doi.org/10.3389/fcell.2021.643942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058364/
https://www.ncbi.nlm.nih.gov/pubmed/33898432
http://dx.doi.org/10.3389/fcell.2021.643942

Ejemplares similares